Trademark applications and grants for Cell Signaling Technology Inc. Cell Signaling Technology Inc has 71 trademark applications. The latest application filed is for "INTRASEQ"
Patent Application | Date |
---|---|
EGFR AND ROS1 KINASE IN CANCER 20220267854 - 17/500122 CROSBY; Katherine Eleanor ;   et al. | 2022-08-25 |
METHODS OF DETECTING A POLYPEPTIDE HAVING ANAPLASTIC LYMPHOMA KINASE ACTIVITY IN KIDNEY CANCER 20220003771 - 17/479010 Haack; Herbert ;   et al. | 2022-01-06 |
COMPOSITIONS FOR DETECTING MUTANT ANAPLASTIC LYMPHOMA KINASE IN LUNG CANCER 20210371933 - 17/102639 Rikova; Klarisa ;   et al. | 2021-12-02 |
ROS KINASE IN LUNG CANCER 20210349095 - 17/377475 Rimkunas; Victoria McGuinness ;   et al. | 2021-11-11 |
MASS SPECTROMETRY ANALYSIS OF MUTANT POLYPEPTIDES IN BIOLOGICAL SAMPLES 20210123924 - 16/890379 Moritz; Albrecht ;   et al. | 2021-04-29 |
NCAGE Code | 3LTH3 | CELL SIGNALING TECHNOLOGY, INC. |
CAGE Code | 3LTH3 | CELL SIGNALING TECHNOLOGY, INC. |
S.A.M. Registration | 3LTH3 [125131669] | CELL SIGNALING TECHNOLOGY, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.